Posted on April 30, 2007 by FMS Global News
Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called “Zorro-LNA,” which has the potential to stop genetic disorders in their tracks. In the study, researchers from the Karolinska Institute in Stockholm, Sweden, describe how they developed Zorro-LNA [...]
Filed under: Article, Britain, Clinical, Diseases, Drugs, Europe, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia News, Fibromyalgia News Deutschland, Fibromyalgia News France, Fibromyalgia News Israel, Fibromyalgia News Jerusalem, Fibromyalgia News Korea, Fibromyalgia News Southeast Asia, Fibromyalgia News Turkey, Fibromyalia News Germany, Genetic Disorders, Global News, Medical Journals, Medical Research, Medical University, News, News Australia, News Canada, News France, News India, News Ireland, News Israel, News Jerusalem, News Korea, News Montreal, News Norway, News Quebec, News Saskatchewan, News Scotland, News Spain, News Sweden, News Turkey, News UK, North Carolina, Ontario, Ontario Genometrics, Ontario Research and Development, Ottawa, Pharmacologic, Pharmacological, Philadelphia, Physiology, RSS, Research, Stockholm, Swedish, Tenderpoints, Therapies, Toronto, US, Universities, Virginia, Washington DC, World, World News | Leave a Comment »
Posted on April 30, 2007 by FMS Global News
1: Nat Rev Drug Discov. 2007 Apr 20; [Epub ahead of print]
Szallasi A, Cortright DN, Blum CA, Eid SR.
Department of Pathology, Monmouth Medical Center, Long Branch, New Jersey 07740 and Drexel University College of Medicine, Philadelphia, USA.
The clinical use of TRPV1 (transient receptor potential vanilloid subfamily, member 1; also known as VR1) antagonists is [...]
Filed under: Analgesics, Britain, Chronic Myofacial Pain, Chronic Pain, Clinical, Clinical Pain, Diseases, Drugs, Europe, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia News, Fibromyalgia News Deutschland, Fibromyalgia News France, Fibromyalgia News Israel, Fibromyalgia News Jerusalem, Fibromyalia News Germany, Global News, Health, Medical, Medical Journals, Medical Research, Medical University, Myofacial Pain Syndrome, Narcotics, News, News Australia, News Canada, News France, News India, News Ireland, News Israel, News Jerusalem, News Korea, News Montreal, News Norway, News Quebec, News Saskatchewan, News Scotland, News Spain, News Sweden, News Turkey, News UK, Ontario, Ottawa, Pain Management, Pain Management Clinic, Pain Matrix, Pharmacologic, Pharmacological, Philadelphia, RSS, Research, Stockholm, Swedish, Tenderpoints, Toronto, US, Universities, Virginia, Washington DC, World, World News | Leave a Comment »
Posted on April 29, 2007 by FMS Global News
Contact: Katie Gazella
kgazella@umich.edu
734-764-2220
University of Michigan Health System
Anti-inflammatory compound inhibits production of molecules that cause destruction of cartilage, bone
ANN ARBOR, Mich. — A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.
The study, presented April 29 at the [...]
Filed under: Arthritis, Autoimmune Diseases, Britain, Clinical, Diseases, Europe, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia News, Fibromyalgia News Deutschland, Fibromyalgia News France, Fibromyalgia News Israel, Fibromyalgia News Jerusalem, Fibromyalia News Germany, Global News, Health, Medical, Medical Journals, Medical Research, Medical University, News, News Australia, News Canada, News France, News India, News Ireland, News Israel, News Jerusalem, News Montreal, News Norway, News Quebec, News Saskatchewan, News Scotland, News Spain, News Sweden, News UK, Ontario, Osteoarthritis, Ottawa, Pain, RSS, Research, Rheumatism, Rheumatoid Arthritis, Stockholm, Swedish, Tenderpoints, Toronto, US, Universities, University of Michigan, World, World News | 4 Comments »
Posted on April 28, 2007 by FMS Global News
Contact: Kristen Bole
kbole@pubaff.ucsf.edu
415-476-2557
University of California – San Francisco
The amount Americans spent on arthritis medications more than doubled between 1998 and 2003, due to the fast-rising number of people with the disease, increases in the number of medications they take each month and the inflation-adjusted cost per prescription, according to a new study led by [...]
Filed under: Arthritis, Diseases, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Global News, Health, Medical, Medical Research, Medical University, News, News Australia, News Canada, News France, News India, News Ireland, News Israel, News Korea, News Montreal, News Norway, News Quebec, News Saskatchewan, News Scotland, News Spain, News Sweden, News UK, Ontario, Osteoarthritis, Ottawa, RSS, Research, Rheumatism, Rheumatoid Arthritis, Tenderpoints, Toronto, US, Universities, World, World News | 1 Comment »
Posted on April 26, 2007 by FMS Global News
Press Release
25th April 2007
Talk by world-leading medical expert, Professor Basant K. Puri, on the natural treatment of M.E. and Fibromyalgia for World Fibromyalgia [...]
Filed under: Awareness, Chronic Fatigue Syndrome, Europe, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia News, Global News, Health, News, News Australia, News Canada, News France, News Ireland, News Scotland, News UK, RSS, Support Groups, Tenderpoints, World News | 1 Comment »
Posted on April 24, 2007 by FMS Global News
Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
WINSTON-SALEM, N.C. – The U.S. Food and Drug Administration (FDA) has caused an unnecessary scare about some pain relievers by adding a warning to drugs that are safe, says Curt Furberg, M.D., Ph.D., from Wake Forest University School of Medicine. At the same time, he says the [...]
Filed under: Analgesics, Arthritis, Article, Drugs, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Global News, Health, Medical, News, RSS | 2 Comments »